Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert's syndrome in Taiwanese adults

Clinical Genetics

Volumn 72, Issue 4, 2007, Pages 321-328

  Teng, H C ^a   Huang, M J ^b   Tang, K S ^c   Yang, S S ^b   Tseng, C S ^d   Huang, Ching Shan ^b,c  

^a FOOYIN UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c Central Taiwan University of Technology   (Taiwan)

^d YUAN'S GENERAL HOSPITAL   (Taiwan)

Author keywords

Combined genotypes; Gilbert's syndrome; Haplotype analysis; Linkage disequilibrium

Indexed keywords

ADENINE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A7; GUANINE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GILBERT DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

ALLELES; FEMALE; GENOTYPE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RISK; RISK FACTORS; TAIWAN; VARIATION (GENETICS);

EID: 34548563846     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00873.x     Document Type: Article

References (33)

1. Fevery J. Pathogenesis of Gilbert's syndrome. Eur J Clin Invest 1981: 11: 417-418.
2. de Morais SM, Uetrecht JP, Wells PG. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992: 102: 577-586.
3. Owens D, Evans J. Population studies on Gilbert's syndrome. J Med Genet 1975: 12: 152-156.
4. Raijmakers MT, Jansen PL, Steegers EA et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 2000: 33: 348-351.
5. Radominska-Pandya A, Czernik PJ, Little JM et al. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 1999: 31: 817-899.
6. Mackenzie PI, Walter Bock K, Burchell B et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005: 15: 677-685.
7. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003: 3: 136-158.
8. Iwai M, Maruo Y, Ito M et al. Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 2004: 49: 123-128.
9. Ehmer U, Vogel A, Schutte JK et al. Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 2004: 39: 970-977.
10. Saeki M, Saito Y, Jinno H et al. Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab Pharmacokinet 2005: 20: 85-90.
11. Huang MJ, Yang SS, Lin MS et al. Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World J Gastroenterol 2005: 11: 797-802.
12. Guillemette C, Ritter JK, Auyeung DJ et al. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: Functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000: 10: 629-644.
13. Huang YH, Galijatovic A, Nguyen N et al. Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 2002: 12: 287-297.
14. Girard H, Court MH, Bernard O et al. Identification of common polymorphisms in the promoter of the UGT1A9 gene: Evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 2004: 14: 501-515.
15. Jinno H, Saeki M, Tanaka-Kagawa T et al. Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10. Drug Metab Dispos 2003: 31: 528-532.
16. Bosma PJ, Chowdhury JR, Bakker C et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995: 333: 1171-1175.
17. Huang CS, Huang MJ, Lin MS et al. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genomics 2005: 15: 43-50.
18. Maruo Y, Nishizawa K, Sato H et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999: 103: 1224-1227.
19. Ando Y, Chida M, Nakayama K et al. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 1998: 8: 357-360.
20. Tseng CS, Tang KS, Lo HW et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 2005: 100: 1758-1763.
21. Huang CS, Luo GA, Huang ML et al. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 2000: 10: 539-544.
22. Li SS, Khalid N, Carlson C et al. Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 2003: 4: 513-522.
23. Zhao LP, Li SS, Khalid N. A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. Am J Hum Genet 2003: 72: 1231-1250.
24. Bosma PJ, van der Meer IM, Bakker CT et al. UGT1A1*28 allele and coronary heart disease: The Rotterdam Study. Clin Chem 2003: 49: 1180-1181.
25. Hsieh SY, Wu YH, Lin DY et al. Correlation of mutational analysis to clinical features in Taiwanese patients with Gilbert's syndrome. Am J Gastroenterol 2001: 96: 1188-1193.
26. Huang CS, Chang PF, Huang MJ et al. Relationship between bilirubin UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res 2002: 52: 601-605.
27. Lankisch TO, Vogel A, Eilermann S et al. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene. Mol Pharmacol 2005: 67: 1732-1739.
28. Innocenti F, Liu W, Chen P et al. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenet Genomics 2005: 15: 295-301.
29. Costa E, Vieira E, Dos Santos R. The polymorphism c.-3279T>G in the phenobarbital-responsive enhancer module of the bilirubin UDP-glucuronosyltransferase gene is associated with Gilbert syndrome. Clin Chem 2005: 51: 2204-2206.
30. Maruo Y, D'Addario C, Mori A et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum Genet 2004: 115: 525-526.
31. Gong QH, Cho JW, Huang T et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001: 11: 357-368.
32. Lee SK, Lee BM. Oxidation of erythrocyte protein and lipid, and hemolysis in rabbit red blood cells treated with benzo[a]pyrene or adriamycin. J Toxicol Environ Health 1997: 51: 557-569.
33. Kaplan M, Hammerman C, Rubaltelli FF et al. Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism. Hepatology 2002: 35: 905-911.